Cancer Predispostitions Flashcards
Hereditary Retinoblastoma Clinical
Sensitive to radiation, trilateral RB
Hereditary Retinoblastoma Screening
Birth -8wks non-sedated eye exam q2-4 wks
8wks-12mo monthly sedated eye exam
12-24 mo sedated eye exam q 2mo
24-36 mo q3 mo
36 mo-48 mo q4mo
48 mo-60 mo q6 mo the stop
NF1 Clinical
High variable expressivity
LGG and optic pathway glioma
MPNST
Leukemia (JMML)
GIST and duodenal carcinoid tumors
Breast Cancer
Plexiform neurofibromas
Pheochromocytomas
Embryonal rhabdomyosarcomas
Iris Hamartomas (Lisch nodules)
Sphenoid wing dysplasia macrocephaly
NF2 clinical
bilateral vestibular schwannomas
meningioma
ependymoma
astrocytoma
intradermal schwannoma
retinal hamartomas
cortical wedge cataract
NF2 Screening
Annual brain MRI starting at age 10y
annual audiology exam
Nevoid Basal Cell Carcinoma (Gorlin Syndrome) Gene
PTCH1 & SUFU
Nevoid Basal Cell Carcinoma (Gorlin Syndrome) Clinical
Desmoplastic nodular medulloblastoma (SUFU - SHH type)
Basal cell carcinoma
Keratogenic cysts of the Jaw (PTCH1)
Cardiac fibromas
Ovarian fibromas
Macrocephaly
Milia
bifid ribs, wedge shaped vertebrae
Nevoid Basal Cell Carcinoma (Gorlin Syndrome) Screening
Annual derm exam starting at 10 yrs
SUFU brain MRI q3-4 mo until age 3y then q6 mo until age 5y
PTCH1 panorex annual
Von Hippel-Lindau Clinical
hemangioblastoma
retinal angioma
renal cell carcinoma later in life
pheochromocytoma
endodermal sinus tumor (ear)
Von Hippel-Lindau Screening
Annual eye exam starting at birth
brain and spine MRI every other year starting at 8yrs
annual abdomen MRI starting at 10 yrs
Audiogram every other year starting at 5 yrs
Rhabdoid Tumor Predisposition Type 1 Gene
SMARCB1
Rhabdoid Tumor Predisposition Type 1 Clinical
ATRT 30% of ATRT have germline RTP mutation
schwannomas
meningiomas
Rhabdoid tumor of the kidney
Rhabdoid Tumor Predisposition Type I screening
MRI brain q3mo until 5yrs
annual abdominal US
Constitutional Mismatch Repair Deficiency (CMMRD) - Lynch Syndrome Gene
MSH2, MLH1, MSH6, PMS2
Autosomal recessive
High penetrance
variable expressivity
Constitutional Mismatch Repair Deficiency (CMMRD) - Lynch Syndrome Clinical
Hypermutated g=high grade glioma
colon cancer
leukemia
cafe-au-lait spots
Constitutional Mismatch Repair Deficiency (CMMRD) - Lynch Syndrome Screening
annual whole body MRI
annual CBC
q4mo abdominal US
Li-Fraumeni Gene
TP53 on chromosome 17
Li-Fraumeni Clinical
Osteosarcoma <5yrs
adrenocortical carcinoma
anaplastic rhabdomyosarcoma
Choroid plexus carcinoma
Triple positive breast cancer
hypodiploid B-ALL
infiltrative astrocytoma, high grade gliomas
Li-Fraumeni Screening
Annual whole body MRI
Annual brain MRI
Abdominal US q3-4 mo
Annual skin exam
Rothmund Thomson Syndrome Type II Gene
RECQL4
Autosomal Recessive
Rothmund Thomson Syndrome Type II Clinical
Osteosarcoma - multicentric
poikiloderma
short
sparse hair
juvenile cataracts
skeletal abnormalities
radial ray defects
premature aging
PTEN Harmartoma Syndrome (Cowden) Gene
PTEN
PTEN Hamartoma Syndrome (Cowden) Clinical
Papillary thyroid cancer
Lipomas
GI hamartomas
Breast cancer
endometrial cancer young (40 y)
Macrocephaly
IQ
Trichilemmoma (subq lumps)
PTEN Hamartoma (Cowden) Syndrome Screening
Every other year thyroid US starting 7 yrs
MEN1 Clinical
Pancreatic neuroendocrine tumors (secrete insulin)
Pituitary adenomas (secrete prolactin)
Parathyroid tumors (primary hyperparathyroidism)
MEN2A Gene
RET activating
MEN2A Clinical
95% of MEN2
100% medullary thyroid cancer
primary hyperparathyroidsim
MEN2A screening
thyroidectomy by age 5 y
Neck US CEA level calcitonin Q6 mo x2 then annual
plasma metanephrines annual
MEN2B Gene
RET activating
MEN2B Clinical
5% MEN2
100% very aggressive medullary thyroid cancer (<1 yr)
50% pheochromocytoma
No primary hyperparathyroidsim
Mucosal neuromas
intestinal gnaglioneuromas
marfanoid